Continuous Wireless Monitoring of Vital Signs and Automated Alerts of Postsurgical Patient Deterioration.
NCT ID: NCT04640415
Last Updated: 2023-06-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
400 participants
INTERVENTIONAL
2021-01-11
2023-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
We hypothesize that continuous vital signs monitoring, and real-time alerts will reduce the cumulative duration of severely deviating vital signs.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Automated Alerts of Patient Deterioration vs. Routine Monitoring of High-risk Patients Admitted to Medical Wards
NCT04661748
Continuous and Wireless Vital Sign Monitoring in Patients at Home After Acute Medical Admission
NCT05536206
Continuous Wireless Monitoring of Vital Signs and Automated Alerts in Participants at Home and During Hospitalization
NCT05378139
Does Continuous Vital Sign Monitoring Increase Investigations and Interventions in Complication-free Patients?
NCT06361862
Continuous Monitoring of Vital Signs at Home (WARD HOME II)
NCT06077851
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No alarms
Patients will be connected to monitoring equipment, registering vital sign data, but data will be blinded to clinical staff.
No interventions assigned to this group
Active alarms
Patients will be connected to monitoring equipment, registering data, and data will be available to clinical staff, including alarms for vital sign deterioration.
Active Alarms
Intervention consists of actively alerting staff personnel if physiologic vital signs, deviates from certain thresholds for more than a set duration. Continuous vital sign data will also be available to clinical staff.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Active Alarms
Intervention consists of actively alerting staff personnel if physiologic vital signs, deviates from certain thresholds for more than a set duration. Continuous vital sign data will also be available to clinical staff.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Estimated duration of surgery ≥2 hours and at least two expected overnight stays.
* Randomization and commencement of continuous wireless monitoring possible within 24 hours postoperatively
Exclusion Criteria
* Allergy to plaster or silicone.
* Impaired cognitive function (in uncertain cases assessed by a Mini Mental State Examination\] score \< 24)
* Patients admitted for palliative care only (i.e. no active treatment).
* Planned admission to unit using continuous vital sign monitoring (i.e. an intermediary care/telemetry unit).
* Patients previously enrolled in the medical WARD RCT.
* Patients with a pacemaker or Implantable Cardioverter Defibrillator (ICD) device.
* Inability to give informed consent.
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aarhus University Hospital
OTHER
Odense University Hospital
OTHER
Bispebjerg Hospital
OTHER
Technical University of Denmark
OTHER
Rigshospitalet, Denmark
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jesper Mølgaard
MD, Ph.d student
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jesper Mølgaard, MD
Role: PRINCIPAL_INVESTIGATOR
Rigshospitalet, Denmark
Eske K Aasvang, MD, DMSc
Role: STUDY_CHAIR
Rigshospitalet, Denmark
Christian S Meyhoff, MD, PhD
Role: STUDY_CHAIR
Bispebjerg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bispebjerg Hospital
Copenhagen NV, Copenhagen, Denmark
Rigshospitalet
Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Molgaard J, Gronbaek KK, Rasmussen SS, Eiberg JP, Jorgensen LN, Achiam MP, Rohrsted M, Singh UM, Hoang TH, Sogaard M, Meyhoff CS, Aasvang EK. Continuous Vital Sign Monitoring at the Surgical Ward for Improved Outcomes After Major Noncardiac Surgery: A Randomized Clinical Trial. Anesth Analg. 2025 Oct 1;141(4):807-817. doi: 10.1213/ANE.0000000000007606. Epub 2025 Jul 1.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Statistical Analysis Plan
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-20034555
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.